openPR Logo
Press release

Projected Expansion of Overactive Bladder Market by 2032, Analysis by DelveInsight | Urovant Sciences, Bayer, Taiho Pharmaceutical, Astellas Pharma Inc, Kyorin Pharmaceutical, Novartis, Pfizer, GlaxoSmithKline

04-01-2024 01:35 PM CET | Health & Medicine

Press release from: DelveInsight Business Research

Overactive Bladder Market

Overactive Bladder Market

(New York, USA) DelveInsight's Overactive Bladder Market Insights report includes a comprehensive understanding of current treatment practices, overactive bladder emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

Discover which therapies are expected to grab the major overactive bladder market share @ https://www.delveinsight.com/report-store/overactive-bladder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key Takeaways from the Overactive Bladder Market Report
• As per DelveInsight analysis, the overactive bladder market is expected to grow positively at a significant CAGR during the study period (2019-2032).
• Leading overactive bladder companies such as Urovant Sciences, Bayer, Taiho Pharmaceutical, Astellas Pharma Inc, Kyorin Pharmaceutical, Novartis, Astellas Pharma US, Pfizer, GlaxoSmithKline, and others are developing novel overactive bladder drugs that can be available in the overactive bladder market in the coming years.
• Some of the key therapies for overactive bladder treatment include URO-902, BAY 1817080, TAC-302, Mirabegron, Vibegron, Darifenacin, Vesicare, SPM 907, Solabegron, Oxybutynin, and others.
• The emerging overactive bladder therapies are in the mid-phase of their clinical trials and are awaiting a launch to make the pipeline robust.
• On March 2024, Imbrium Therapeutics announced a Multicenter, Randomized, Double-blind Placebo-controlled, and Crossover Study to Investigate Effects of V117957 in Female Subjects with Overactive Bladder Syndrome.
• On March 2024, Sarfez Pharmaceuticals announced a Crossover, Double-blinded, Two-period, Study to Evaluate the Effects of Extended Release Torsemide in Patients with Chronic Congestive Heart Failure and Symptoms of Overactive Bladder.
• On Jan 2024, MedtronicNeuro announced a Prospective Study to Assess the Efficacy and Safety of the BlueWind RENOVA iStim™ System in the Treatment of Patients Diagnosed with Overactive Bladder (OASIS - OverActive Bladder StImulation System Study).

Overactive Bladder Overview
Overactive bladder (OAB) is a condition in which a person's need to urinate is so frequent that it negatively affects their life. Urination may be required frequently during the day, at night, or both. Urge incontinence occurs when there is a loss of bladder control. Incontinence affects more than 40% of people with overactive bladder. In contrast, overactive bladder causes 40% to 70% of urinary incontinence. The cause of overactive bladder is unknown. Obesity, caffeine, and constipation are risk factors. Diabetes, poor functional mobility, and chronic pelvic pain may exacerbate the overactive bladder symptoms.
Overactive bladder is characterized by four symptoms: urgency, urinary frequency, nocturia, and urge incontinence. The overactive bladder diagnosis is based primarily on the person's signs and symptoms and excludes other possible causes, such as infection. Urodynamics, a bladder scope, and ultrasound are generally unnecessary. Urine culture may also be performed to rule out infection.

Download the report to understand which factors are driving overactive bladder epidemiology trends @ https://www.delveinsight.com/sample-request/overactive-bladder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Overactive Bladder Epidemiology Segmentation
The overactive bladder market report proffers epidemiological analysis for the study period 2019-2032 in the 7MM segmented into:
• Total Prevalent Cases of Overactive bladder
• Gender-specific Prevalent Cases of Overactive bladder
• Type-specific Prevalent Cases of Overactive bladder
• Diagnosed and Treatable Cases of Overactive bladder

Overactive Bladder Treatment Market
Overactive bladder is a group of symptoms that, while not fatal, can have a negative impact on quality of life. As a result, physicians must carefully balance the potential benefit of a specific overactive bladder treatment against the risk, severity, and reversibility of adverse effects. All patients with overactive bladder should receive behavioral therapies as first-line therapy (e.g., bladder training, bladder-control strategies, pelvic floor muscle training, fluid management). Antimuscarinic agents can be combined with behavioral strategies.
Oral antimuscarinics are second-line therapies for overactive bladder treatment (e.g., darifenacin [Enablex], fesoterodine [Toviaz], oxybutynin [Ditropan], solifenacin [Vesicare], tolterodine [Detrol], trospium[Sanctura]). When choosing between immediate-release and extended-release formulations, the extended-release formulation is preferred due to lower rates of dry mouth. Transdermal oxybutynin (gel [Gelnique] or patch [Oxytrol]) may also be available.

To know more about overactive bladder treatment, visit @ https://www.delveinsight.com/sample-request/overactive-bladder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Key Overactive Bladder Therapies and Companies
• URO-902: Urovant Sciences
• BAY 1817080: Bayer
• TAC-302: Taiho Pharmaceutical
• Mirabegron: Astellas Pharma Inc
• Vibegron: Kyorin Pharmaceutical/Urovant Sciences
• Darifenacin: Novartis
• Vesicare: Astellas Pharma US, Inc.
• SPM 907: Pfizer
• Solabegron: GlaxoSmithKline
• Oxybutynin: Bayer

Learn more about the FDA-approved drugs for overactive bladder @ https://www.delveinsight.com/sample-request/overactive-bladder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Scope of the Overactive Bladder Market Report
• Study Period: 2019-2032
• Coverage: 7MM [The United States, the EU-4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan]
• Key Overactive Bladder Companies: Urovant Sciences, Bayer, Taiho Pharmaceutical, Astellas Pharma Inc, Kyorin Pharmaceutical, Novartis, Pfizer, GlaxoSmithKline, and others
• Key Overactive Bladder Therapies: URO-902, BAY 1817080, TAC-302, Mirabegron, Vibegron, Darifenacin, Vesicare, SPM 907, Solabegron, Oxybutynin, and others
• Therapeutic Assessment: Overactive Bladder current marketed and emerging therapies
• Overactive Bladder Market Dynamics: Attribute Analysis of Emerging Overactive Bladder drugs
• Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
• Unmet Needs, KOL's views, Analyst's views, Overactive Bladder Market Access and Reimbursement

Discover more about overactive bladder drugs in development @ https://www.delveinsight.com/sample-request/overactive-bladder-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr

Table of Contents
1. Overactive Bladder Market Key Insights
2. Overactive Bladder Market Report Introduction
3. Overactive Bladder Market Overview at a Glance
4. Overactive Bladder Market Executive Summary
5. Overactive Bladder Understanding and Overview
6. Overactive Bladder Treatment and Management
7. Overactive Bladder Epidemiology and Patient Population
8. Overactive Bladder Patient Journey
9. Overactive Bladder Marketed Drugs
10. Overactive Bladder Emerging Drugs
11. Seven Major Overactive Bladder Market Analysis
12. Overactive Bladder Market Outlook
13. Potential of Current and Emerging Therapies
14. Overactive Bladder KOL Views
15. Overactive Bladder Market Drivers
16. Overactive Bladder Market Barriers
17. Overactive Bladder Unmet Needs
18. SWOT Analysis
19. Appendix
20. DelveInsight Capabilities
21. Disclaimer
22. About DelveInsight

Trending Reports:
• Asphyxia Market: https://www.delveinsight.com/report-store/asphyxia-market
• Asherman's Syndrome Market: https://www.delveinsight.com/report-store/ashermans-syndrome-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Abetalipoproteinemia Market: https://www.delveinsight.com/report-store/abetalipoproteinemia-market
• Chronic pruritus market: https://www.delveinsight.com/report-store/chronic-pruritus-market
• Hiatal hernia market: https://www.delveinsight.com/report-store/hiatal-hernia-market
• Pediatric obesity market: https://www.delveinsight.com/report-store/pediatric-obesity-market
• Acral Lentiginous Melanoma Market: https://www.delveinsight.com/report-store/acral-lentiginous-melanoma-market
• Anaphylaxis Market: https://www.delveinsight.com/report-store/anaphylaxis-market
• Aortic Stenosis Market: https://www.delveinsight.com/report-store/aortic-stenosis-market
• Binge Eating Disorder Market: https://www.delveinsight.com/report-store/binge-eating-disorders-market
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myelogenous-leukemia-market
• Familial Primary Pulmonary Hypertension Market: https://www.delveinsight.com/report-store/familial-primary-pulmonary-hypertension-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Meningioma Market: https://www.delveinsight.com/report-store/meningioma-market
• Optic Neuritis Market: https://www.delveinsight.com/report-store/optic-neuritis-market
• Partial Seizure Market: https://www.delveinsight.com/report-store/partial-seizure-market
• Progressive Multifocal Leukoencephalopathy Market: https://www.delveinsight.com/report-store/progressive-multifocal-leukoencephalopathy-market
• Alopecia Market: https://www.delveinsight.com/report-store/alopecia-market
• Cluster Headache Market: https://www.delveinsight.com/report-store/cluster-headache-market
• Minimal Residual Disease Market: https://www.delveinsight.com/report-store/minimal-residual-disease-market
• Achondroplasia Market: https://www.delveinsight.com/report-store/achondroplasia-market
• Actinic Keratosis Market: https://www.delveinsight.com/report-store/actinic-keratosis-market
• Aesthetic Implants Market: https://www.delveinsight.com/report-store/aesthetic-implants-market
• Alzheimer Disease Market: https://www.delveinsight.com/report-store/alzheimers-disease-ad-market
• Angioedema Market: https://www.delveinsight.com/report-store/angioedema-market
• Blood Gas And Electrolyte Analyzers Market: https://www.delveinsight.com/report-store/blood-gas-and-electrolyte-analyzers-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Calciphylaxis Market: https://www.delveinsight.com/report-store/calciphylaxis-pipeline-insight
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Chemotherapy Induced Thrombocytopenia Market: https://www.delveinsight.com/report-store/chemotherapy-induced-thrombocytopenia-market-size
• Chronic Lymphocytic Leukemia Cll Market: https://www.delveinsight.com/report-store/chronic-lymphocytic-leukemia-cll-market
• Concussions Market Size: https://www.delveinsight.com/report-store/concussions-market
• Eczema Market: https://www.delveinsight.com/report-store/eczema-market
• Foot And Ankle Devices Market: https://www.delveinsight.com/report-store/foot-and-ankle-devices-market
• Human Papilomavirus Market: https://www.delveinsight.com/report-store/human-papillomavirus-hpv-market
• Hyperhidrosis Market: https://www.delveinsight.com/report-store/hyperhidrosis-market
• Ventricular Hypertrophy Market: https://www.delveinsight.com/report-store/hypertrophic-cardiomyopathy-pipeline-insight
• Cerebral Aneurysm Market: https://www.delveinsight.com/report-store/intracranial-aneurysms-market-insight
• Lewy Body Dementia Market: https://www.delveinsight.com/report-store/lewy-body-dementia-market
• Multiple Myeloma Market: https://www.delveinsight.com/report-store/multiple-myeloma-market
• Pressure Ulcers Market Size: https://www.delveinsight.com/report-store/negative-pressure-wound-therapy-systems-market
• Neuroblastoma Market: https://www.delveinsight.com/report-store/neuroblastoma-market
• Neurostimulation Devices Market: https://www.delveinsight.com/report-store/neurostimulation-devices-market
• Neurovascular Devices Market: https://www.delveinsight.com/report-store/neurovascular-devices-interventional-neurology-market
• Nsclc Market: https://www.delveinsight.com/report-store/non-small-cell-lung-cancer-nsclc-market
• Opioid Induced Constipation Market: https://www.delveinsight.com/report-store/opioid-induced-constipation-market
• Osteoarthritis Market: https://www.delveinsight.com/report-store/osteoarthritis-market
• Parkinson's Disease Market: https://www.delveinsight.com/report-store/parkinsons-disease-market-size-analysis-treatment
• Pruritus Market: https://www.delveinsight.com/report-store/pruritus-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Chronic Lymphocytic Leukemia Market: https://www.delveinsight.com/report-store/relapsed-chronic-lymphocytic-leukemia-cll-market
• Ventilator Market: https://www.delveinsight.com/report-store/ventilators-market

Contact Us:
Ankit Nigam
Assistant Manager Marketing
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com/consulting

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Projected Expansion of Overactive Bladder Market by 2032, Analysis by DelveInsight | Urovant Sciences, Bayer, Taiho Pharmaceutical, Astellas Pharma Inc, Kyorin Pharmaceutical, Novartis, Pfizer, GlaxoSmithKline here

News-ID: 3447727 • Views:

More Releases from DelveInsight Business Research

Global General Surgery Devices Market is expected to grow at a CAGR of 6.3% by 2032 | DelveInsight
Global General Surgery Devices Market is expected to grow at a CAGR of 6.3% by 2 …
General Surgery Devices Market Overview The Global General Surgery Devices Market is projected to grow at a CAGR of 6.34% from 2025 to 2032, driven by the rising burden of chronic diseases, increasing surgical interventions, and the adoption of robotic-assisted and minimally invasive techniques. Covering instruments such as handheld tools, electrosurgical devices, laparoscopic systems, wound closure products, and disposables, these devices play a critical role in diverse procedures, including orthopedic, cardiovascular,
Intratumoral Cancer therapies Market Outlook 2034 - Clinical Trials, Market Size, Medication, Prevalence, Companies by DelveInsight
Intratumoral Cancer therapies Market Outlook 2034 - Clinical Trials, Market Size …
Intratumoral Cancer Market Summary Intratumoral cancer therapies involve direct delivery into tumors, enabling localized targeting with minimal damage to surrounding tissue. Within the 7MM, non-melanoma cancers represent the largest share of cases and are expected to rise at ~2% annually, while in the US, breast cancer accounts for about 30% of cases with a growing incidence rate for intratumoral therapies. Currently, IMLYGIC is the only FDA-approved intratumoral therapy for melanoma, holding
Bispecific and Trispecific Antibodies Market Projected to Experience Significant Growth by 2035, Reports DelveInsight
Bispecific and Trispecific Antibodies Market Projected to Experience Significant …
Bispecific antibodies represent an innovative class of therapies designed to address complex diseases by simultaneously binding two targets with a single molecule. Most currently approved bispecifics are for oncology, particularly multiple myeloma and diffuse large B-cell lymphoma (DLBCL). Beyond oncology, only HEMLIBRA and VABYSMO are approved for conditions such as hemophilia A, wet age-related macular degeneration, and diabetic macular edema, while KIMMTRAK is approved for uveal melanoma. The pipeline remains
Narcolepsy Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight
Narcolepsy Pipeline 2025: Therapies, MOA Insights, and Key Clinical Trial Update …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Narcolepsy pipeline constitutes 10+ key companies continuously working towards developing 12+ Narcolepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Narcolepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed

All 5 Releases


More Releases for Market:

Sorbitol Market Forecast, Sorbitol Market Analysis, Sorbitol Market Growth, Sorb …
The Sorbitol Market has been fragmented based on the productivity of several companies; therefore, each segment and its sub-segments are analyzed in the research report. Furthermore, the report offers 360 views on historical and upcoming growth based on volume, value, production, and consumption. Moreover, it classifies depend on sub-segments, key segments as per the significant regions and offers an in-depth analysis on the competitive edge of the market. This report
Esterquats Market, Esterquats Market Size, Esterquats Market Share, Esterquats M …
The "Esterquats Market" is a dynamic and rapidly evolving sector, with significant advancements and growth anticipated by 2031. Comprehensive market research reveals a detailed analysis of market size, share, and trends, providing valuable insights into its expansion. This report delves into segmentation and definition, offering a clear understanding of market components and drivers. Employing SWOT and PESTEL analyses, the study evaluates the market's strengths, weaknesses, opportunities, and threats, alongside political,
Syringe and Needle Market Size, Market Share, Market Trends, Market Analysis, Ma …
Market Overview: The global syringe and needle market is a critical component of the healthcare industry, serving as indispensable tools for administering medications, vaccines, and drawing blood samples. This market is characterized by a diverse range of products catering to various medical needs, including disposable syringes, safety syringes, insulin syringes, hypodermic needles, and more. This article provides an in-depth analysis of the syringe and needle market, focusing on its market overview,
India Tractor Market, Tractor Industry, Market Revenue, Market Growth Analysis, …
How Is India Tractor Market Positioned? In India two-third population is engaged in Agriculture. Tractors form an essential part of this sector. They bring the required efficiency and productivity country needs in its agricultural activity to compete on the international level. The Indian tractor Industry has made preponderant improvement in production capacity and in terms of production volumes. The industry has been successful in indigenization of the technology. The volume growth
Global Optical Interconnects Market, Market Size, Market Shares, Market Growth A …
In integrated circuits, optical interconnects majorly refers to a system of transmitting signals from one fragment of an integrated circuit to another part which is using light. Optical interconnects have been in high demand due to the high latency and power consumption incurred by conventional metal interconnects in conveying electrical signals over long distances, such as in interconnects classed as global interconnects. The International Technology Roadmap for Semiconductors (ITRS) has emphasized
Global Cash Registers Market, Market Growth Analysis, Market Revenue, Market Out …
A cash register or automatic money handling system is a motorized or electric device for registration and calculating dealings at a point of sale. It is typically devoted to a drawer for storage cash and additional valuables. A modern cash register is generally attached to a printer which can print out incomes for record-keeping determinations. The electronics cash register delivers numerous features likes mall price and informal admittance. The rising acceptance of electronic cash register by